Drug Shortage Report for ENABLEX
| Report ID | 61661 |
| Drug Identification Number | 02273225 |
| Brand name | ENABLEX |
| Common or Proper name | darifenacin hydrobromide |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DARIFENACIN |
| Strength(s) | 15MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | Bottles of 100 |
| ATC code | G04BD |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2018-09-17 |
| Estimated end date | 2018-11-15 |
| Actual end date | 2018-11-15 |
| Shortage status | Resolved |
| Updated date | 2023-08-16 |
| Company comments | Reason for Shortage: Production Delay For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com or by fax at 1-519-751-9149. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-09-17 | English | Compare |
| v2 | 2023-08-16 | English | Compare |
| v3 | 2023-08-16 | French | Compare |
Showing 1 to 3 of 3